JP2010535799A5 - - Google Patents

Download PDF

Info

Publication number
JP2010535799A5
JP2010535799A5 JP2010520272A JP2010520272A JP2010535799A5 JP 2010535799 A5 JP2010535799 A5 JP 2010535799A5 JP 2010520272 A JP2010520272 A JP 2010520272A JP 2010520272 A JP2010520272 A JP 2010520272A JP 2010535799 A5 JP2010535799 A5 JP 2010535799A5
Authority
JP
Japan
Prior art keywords
methoxy
cyclohexyl
indolo
benzazepine
sulfonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010520272A
Other languages
English (en)
Japanese (ja)
Other versions
JP5406837B2 (ja
JP2010535799A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/072295 external-priority patent/WO2009023487A1/en
Publication of JP2010535799A publication Critical patent/JP2010535799A/ja
Publication of JP2010535799A5 publication Critical patent/JP2010535799A5/ja
Application granted granted Critical
Publication of JP5406837B2 publication Critical patent/JP5406837B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010520272A 2007-08-09 2008-08-06 C型肝炎を治療するための四環系化合物 Expired - Fee Related JP5406837B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US95481307P 2007-08-09 2007-08-09
US60/954,813 2007-08-09
PCT/US2008/072295 WO2009023487A1 (en) 2007-08-09 2008-08-06 Tetracyclic compounds for the treatment of hepatitis c

Publications (3)

Publication Number Publication Date
JP2010535799A JP2010535799A (ja) 2010-11-25
JP2010535799A5 true JP2010535799A5 (https=) 2011-09-22
JP5406837B2 JP5406837B2 (ja) 2014-02-05

Family

ID=40002880

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010520272A Expired - Fee Related JP5406837B2 (ja) 2007-08-09 2008-08-06 C型肝炎を治療するための四環系化合物

Country Status (7)

Country Link
US (1) US7642251B2 (https=)
EP (1) EP2178878B1 (https=)
JP (1) JP5406837B2 (https=)
CN (1) CN101821268B (https=)
AT (1) ATE551343T1 (https=)
ES (1) ES2383247T3 (https=)
WO (1) WO2009023487A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005049622A1 (ja) * 2003-11-19 2005-06-02 Japan Tobacco Inc. 5-5員縮合複素環化合物及びそのhcvポリメラーゼ阻害剤としての用途
US20070049593A1 (en) * 2004-02-24 2007-03-01 Japan Tobacco Inc. Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor
US7659263B2 (en) 2004-11-12 2010-02-09 Japan Tobacco Inc. Thienopyrrole compound and use thereof as HCV polymerase inhibitor
US8143243B2 (en) * 2007-08-09 2012-03-27 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
KR20100108341A (ko) * 2007-11-20 2010-10-06 브리스톨-마이어스 스큅 컴퍼니 시클로프로필 융합된 인돌로벤즈아제핀 hcv ns5b 억제제
US8129367B2 (en) * 2007-11-21 2012-03-06 Bristol-Myers Squibb Company Compounds for the treatment of Hepatitis C
KR20100124848A (ko) 2008-03-27 2010-11-29 브리스톨-마이어스 스큅 컴퍼니 방향족 헤테로시클릭 융합된 인돌로벤자디아제핀 hcv ns5b 억제제
US8133884B2 (en) * 2008-05-06 2012-03-13 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
US8143244B2 (en) * 2009-02-26 2012-03-27 Bristol-Myers Squibb Company Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
US20190127365A1 (en) 2017-11-01 2019-05-02 Merck Sharp & Dohme Corp. Inhibitors of hepatitis c virus replication
SG174929A1 (en) * 2009-03-27 2011-11-28 Merck Sharp & Dohme Inhibitors of hepatitis c virus replication
JP2013540122A (ja) 2010-09-29 2013-10-31 メルク・シャープ・エンド・ドーム・コーポレイション 縮合四環式化合物誘導体およびウィルス疾患治療のためのそれの使用方法
WO2012122716A1 (en) 2011-03-17 2012-09-20 Merck Sharp & Dohme Corp. Tetracyclic xanthene derivatives and methods of use thereof for treatment of viral diseases
WO2014110687A1 (en) 2013-01-16 2014-07-24 Merck Sharp & Dohme Corp. Thiazolyl-substitued tetracyclic compounds and methods of use thereof for treatment of viral diseases
CN105440048A (zh) * 2014-09-28 2016-03-30 复旦大学 1,3-苯并二噁茂类化合物山芝麻素及其药物用途

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20090250T1 (hr) 2004-02-24 2009-06-30 Japan Tobacco Kondenzirani heterociklički spojevi i njihova upotreba kao inhibitora hcv polimeraze
US7153848B2 (en) * 2004-08-09 2006-12-26 Bristol-Myers Squibb Company Inhibitors of HCV replication
EP1807403A2 (en) 2004-10-26 2007-07-18 Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. Tetracyclic indole derivatives as antiviral agents
GB0518390D0 (en) 2005-09-09 2005-10-19 Angeletti P Ist Richerche Bio Therapeutic compounds
US7399758B2 (en) * 2005-09-12 2008-07-15 Meanwell Nicholas A Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
US7473688B2 (en) * 2005-09-13 2009-01-06 Bristol-Myers Squibb Company Indolobenzazepine HCV NS5B inhibitors
US7456165B2 (en) * 2006-02-08 2008-11-25 Bristol-Myers Squibb Company HCV NS5B inhibitors
GB0608928D0 (en) 2006-05-08 2006-06-14 Angeletti P Ist Richerche Bio Therapeutic agents
US7456166B2 (en) * 2006-05-17 2008-11-25 Bristol-Myers Squibb Company Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
US7521441B2 (en) * 2006-05-22 2009-04-21 Bristol-Myers Squibb Company Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
JP5205370B2 (ja) * 2006-05-25 2013-06-05 ブリストル−マイヤーズ スクイブ カンパニー シクロプロピル縮合インドロベンゾアゼピンhcvns5b阻害剤
WO2007140200A2 (en) * 2006-05-25 2007-12-06 Bristol-Myers Squibb Company Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
US7452876B2 (en) * 2006-06-08 2008-11-18 Bristol-Myers Squibb Company Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
US7541351B2 (en) * 2007-01-11 2009-06-02 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
US7517872B2 (en) * 2007-02-22 2009-04-14 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
US7538102B2 (en) * 2007-03-14 2009-05-26 Bristol-Myers Squibb Company Compounds for the treatment of Hepatitis C
US7521444B2 (en) * 2007-03-14 2009-04-21 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
US7541353B2 (en) * 2007-03-14 2009-06-02 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
US7547690B2 (en) * 2007-03-14 2009-06-16 Bristol-Myers Squibb Company Compounds for the treatment of Hepatitis C
US7538103B2 (en) * 2007-03-15 2009-05-26 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C

Similar Documents

Publication Publication Date Title
JP2010535799A5 (https=)
JP7741282B2 (ja) ユビキチンプロテオソーム経路を介してbtkを分解するための二官能性化合物
RU2401265C2 (ru) Соединения и композиции в качестве ингибиторов протеинкиназы
KR20220112273A (ko) 유비퀴틴 프로테오솜 경로를 통해 btk를 분해하기 위한 이작용성 화합물
JP2006520805A5 (https=)
RU2018138047A (ru) Гетероциклические вещества - агонисты gpr119
RU2012136643A (ru) [5,6]- гетероциклическое соединение
RU2437882C2 (ru) Производные имидазолидинона
JP2010521483A5 (https=)
RU2018138050A (ru) Производные тиазолопиридина как агонисты gpr119
TW201819386A (zh) Shp2磷酸酶抑制劑及其使用方法
JP2013523819A5 (https=)
RU2009148673A (ru) Производные пиразинона и их применение для лечения легочных заболеваний
RU2013155456A (ru) Соединения пирролидинилмочевины и пирролидинилтиомочевины как ингибиторы киназы trka
JP2013544256A5 (https=)
JP2017518348A (ja) Irak4阻害剤としての置換インダゾール化合物
CA2598294A1 (en) Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate derivative
RU2008126398A (ru) Производные гетероарилзамещенного пиперидина в качестве ингибиторов печеночной карнитин пальмитоилтрансферазы (l-cpti)
JP2012501313A5 (https=)
CA2605680A1 (en) Substituted amide derivatives as protein kinase inhibitors
RU2009140149A (ru) Пиримидингидразидные соединения как ингибиторы pgds
IL295076A (en) Piperidinone derivatives as mdm2 inhibitors for cancer therapy
RU2008135690A (ru) Соединения и композиции в качестве ингибиторов протеинкиназы
CA2571627A1 (en) Substituted aryl-amine derivatives and methods of use
JP2018520096A5 (https=)